Deep Longevity

What Deep Longevity does

Deep Longevity Limited is a Hong Kong-headquartered biotechnology company founded in 2020 as a spinout from Insilico Medicine and acquired within weeks by Regent Pacific Group Limited (HKEX: 0575). The company develops AI-powered aging clocks that predict biological and psychological age from multiple data modalities, including standard clinical blood biomarkers, psychological questionnaires, DNA methylation patterns, biometric inputs, and facial images. Its commercially available clocks include Blood Age (analyzing 55 biomarkers across 8 organ systems in V2.0), Mind Age, Epigenetic Age, Biometrics Age, and Face Age, with a Microbiome Age clock in development.

The company's primary commercial offering is the SenoClock SaaS platform, which aggregates all aging clocks behind a web interface and REST API and is deployed on AWS. SenoClock Gold extends the platform for employer wellness programs with workforce-level analytics. A free consumer tool, FuturSelf.AI, exposes Mind Age technology to over 30,000 users and functions as a data-acquisition and lead-generation layer. The company sells primarily through direct enterprise sales to healthcare providers, longevity clinics, insurance companies, employers, diagnostics laboratories, and government health authorities, with custom annual subscriptions and usage-based API pricing.

Deep Longevity derives credibility from peer-reviewed publications in journals such as Aging-US and collaborations with Stanford, Harvard, CUHK, the University of Liverpool, and HKU. The Blood Age clock has been validated as a significant all-cause mortality risk factor in Asian, European, and North American populations, and the Epigenetic Age clock reports approximately 2.77 years of prediction error. With a headcount of 1-10 employees and no disclosed revenue or external funding rounds beyond the initial 2020 investor syndicate, the company operates as a small, parent-backed AI health platform pursuing geographic expansion (U.S. entry planned for Q1 2026) and vertical extension (insurance, diagnostics, employers) rather than scale-driven venture growth.

Name

Deep Longevity

Legal name

Deep Longevity Limited

Website

https://deeplongevity.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Deep Longevity is a Hong Kong-based AI biotechnology company developing aging clocks that predict biological and psychological age from blood biomarkers, DNA methylation, facial images, and questionnaires. It sells its SenoClock SaaS platform and APIs to healthcare providers, insurers, employers, and longevity clinics globally.

Ownership category

akta.pro rank

Product category

Longevity Analytics Software

NAICS

Services for the Elderly and Persons with Disabilities (624120)

akta.pro industry

PRIMARYTHAJAHAI

Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs)

Travel & Hospitality/Tours, Attractions & Experiences/Wellness & Spa Experiences (Retreats, Thermal Baths, Yoga)

SECONDARYHSADAGAK

Healthy Aging & Longevity Lifestyle Coaching

Home & Personal Services/Fitness, Wellness & Personal Training/Health Coaching & Lifestyle Wellness

SECONDARYHLALAFAI

Geriatric, Frailty & Fall-Prevention Remote Monitoring

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

• Biological age prediction
• Aging clock software
• Longevity biomarkers
• Healthspan analytics
• Preventive longevity platform

Headquarters

HQ city

Hong Kong

HQ country

Hong Kong SAR China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SenoClock SaaS Subscription: Enterprise SaaS platform subscription model providing access to all aging clocks and longevity recommendations. Sold to healthcare providers, longevity clinics, insurance companies, and corporate wellness programs. Pricing is custom based on scale of operations.
2. API Access and Integration: Longevity-as-a-Service providing aging clock technologies via cloud APIs. Organizations, platforms, and applications integrate biological age predictions and health insights. Commercial terms vary based on usage volume and integration scope.
3. Enterprise Licensing (SenoClock Gold): Employee wellness platform for employers offering comprehensive health tracking, biological age monitoring, and organizational health analytics. White-label and customization options available for enterprise deployments.
4. Trial/Demo Access: Limited-period trial and demo access for hospitals and businesses to test aging clock functionality before commercial commitment.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Core offering

Deep Longevity develops and commercializes AI-powered aging clocks that predict biological age from blood biomarkers, psychological questionnaires, DNA methylation, biometrics, and facial images. The company delivers these capabilities via its SenoClock SaaS platform, the SenoClock Gold employer wellness platform, and Longevity-as-a-Service APIs for healthcare providers, longevity clinics, insurance companies, employers, and government health authorities.

Product overview

Deep Longevity operates a platform-plus-modules architecture centered on AI-powered aging clocks that measure biological and psychological age. The core SenoClock SaaS platform hosts all commercially available aging clocks (Blood Age, Mind Age, Epigenetic Age, Biometrics Age, Face Age) with Microbiome Age in development. Blood Age analyzes blood biomarkers to predict biological age and organ health; Mind Age evaluates psychological well-being from questionnaires; Epigenetic Age measures DNA methylation patterns; Biometrics Age uses simplified blood and biometric inputs; Face Age derives aging signals from facial imaging. SenoClock Gold extends the platform for employer wellness programs with workforce-level analytics. FuturSelf.AI provides free consumer access to Mind Age technology. All clocks are accessible via REST APIs enabling Longevity-as-a-Service integration into third-party applications.

Differentiator

Problem solved

Functional benefit

Brands

• SenoClock: SaaS platform providing access to all Deep Longevity aging clocks including Blood Age, Mind Age, Epigenetic Age, Biometrics Age, and Face Age for enterprise customers.
• SenoClock Gold
• Blood Age
• Mind Age
• Epigenetic Age
• Biometrics Age
• Face Age

Products and services

• SenoClock Web-based SaaS platform providing enterprise access to all aging clocks (Blood Age, Mind Age, Epigenetic Age, Biometrics Age) delivering biological age predictions, organ health scores, and personalized health recommendations via web interface and API for healthcare providers, longevity clinics, hospitals, and research institutions.
• SenoClock Gold Employer-focused wellness platform extending SenoClock capabilities with employee health tracking dashboards, journaling features, and organizational-level aggregate analytics enabling HR administrators to monitor workforce biological age trends and mental well-being metrics.
• Blood Age Clock AI-powered aging clock that analyzes standard clinical blood reports to predict biological age, assess organ health across 8 key systems, and provide personalized recommendations for diet, exercise, supplements, and lifestyle modifications.
• Mind Age Clock Psychological aging clock that estimates mental/lifestyle age based on psychological questionnaire responses using ensemble of deep learning models trained on MIDUS and NHANES datasets, providing personalized psychological improvement tips and well-being trajectory analysis.
• Epigenetic Age Clock Biological aging measurement derived from DNA methylation patterns in blood samples using scientifically validated machine-learning models trained on large population datasets, providing approximately 2.77 years typical prediction error.
• Biometrics Age Clock Aging intensity measurement using proprietary aging clock models examining cellular aging signs in blood and body structures, requiring only 17 blood parameters and 4 biometrics, tailored for individuals aged 20-65 years.
• Face Age Clock AI-powered biological aging indicator derived from facial and skin image analysis using computer vision and deep learning models, evaluating facial structure and skin features (wrinkles, pores, oiliness, elasticity, hydration, pigmentation, texture) to estimate biological age.
• FuturSelf.AI Free consumer-facing web service providing psychological age assessment based on MindAge clock technology, featuring questionnaire-based evaluation, mental health risk prediction, well-being trajectory analysis, and SOM-based personalized recommendations.
• Longevity-as-a-Service API Cloud REST APIs providing programmatic access to all aging clocks, documented via Swagger (Open API 3.0), with JWT/API key authentication and JSON format for third-party integration of biological age predictions.

Quantifiable outcome

• Blood Age predictions validated as significant all-cause mortality risk factor in Asian, European, and North American populations
• +3 more outcomes

Named customers14 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

Scale indicators3 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Insilico Medicine: Insilico Medicine is the AI-driven longevity biotech from which Deep Longevity was originally spun out. Both companies apply deep learning to aging biomarkers and longevity drug discovery, share scientific leadership (Alex Zhavoronkov), and compete for the same enterprise customers and insurance partnerships.
• Elysium Health: Elysium Health commercializes consumer longevity products (e.g., Basis supplement, Index biological age test) using AI-derived biomarkers and epigenetic clocks. It targets overlapping customer segments — health-conscious consumers, longevity clinics, and insurers — with a similar combination of biological-age measurement and personalized intervention recommendations.
• Tally Health: Tally Health offers a consumer biological age test (TallyAge) based on epigenetic methylation analysis and pairs it with personalized longevity protocols. It competes directly with Deep Longevity's Epigenetic Age and recommendation engine for consumer mindshare and clinical partnerships.
• TruDiagnostic: TruDiagnostic provides commercial epigenetic age testing and biological age reports to clinicians, researchers, and consumers using DNA methylation arrays. It is a direct competitor in the epigenetic-clock segment where Deep Longevity's Epigenetic Age clock competes, and shares the same enterprise LIMS/clinical channel.
• InsideTracker: InsideTracker analyzes blood biomarkers to generate personalized longevity, performance, and wellness recommendations for consumers, athletes, and corporate wellness programs. It directly overlaps with Deep Longevity's Blood Age clock and SenoClock Gold employer-wellness offering across both B2C and B2B channels.
• Fountain Life: Fountain Life operates premium longevity and preventive-health clinics that combine advanced diagnostics, AI imaging, and biomarker analysis. It represents the same convergence of AI aging analytics and clinical service delivery that Deep Longevity enables for its hospital and clinic customers.

Broad incumbents

• Human Longevity Inc. Human Longevity Inc. (HLI) is a comprehensive longevity diagnostics and genomics company offering whole-genome sequencing, advanced imaging, and AI-driven health analytics. Deep Longevity advisor Wei-Wu He serves as HLI's Executive Chairman, evidencing direct overlap in the AI-aging biomarker space; HLI's broader portfolio positions it as a larger incumbent rather than a point-solution peer.
• Thorne HealthTech: Thorne is an established nutritional supplement and health-data brand that has expanded into biological age testing (e.g., Thorne Age Test) and personalized wellness programs. It competes with Deep Longevity at the intersection of supplements, biomarker testing, and consumer longevity, but as a much larger and broader incumbent.

Emerging players

• ZOE: ZOE runs a personalized nutrition platform combining continuous glucose monitoring, blood fat responses, and gut microbiome analysis with AI-generated dietary recommendations. It overlaps with Deep Longevity in the biomarker-to-personalized-recommendation loop and targets the same health-conscious consumer segment.
• Function Health: Function Health offers comprehensive annual blood testing with AI-driven interpretation, organ system scoring, and personalized health insights for a consumer subscription fee. It is an emerging point-solution competitor in the blood-biomarker-to-longevity-insights category where Deep Longevity's Blood Age clock operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Deep_Longevity
• YouTubeyoutube.com/@deeplongevity6822
• Facebookfacebook.com/DeepLongevity
• LinkedInlinkedin.com/company/deep-longevity
• Instagraminstagram.com/deep_longevity

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deep Longevity